Next-Generation Immunotherapy Shows Promise for Early-Stage Prostate Cancer
A multi-institutional study found that pairing an investigational immunotherapy with hormone therapy before surgery reduced regulatory T cells in prostate tumors and improved cancer-free outcomes in high-risk patients.